Disease | malignant glioma |
Symptom | C0021079|immunosuppression |
Sentences | 2 |
PubMedID- 21725605 | Transforming growth factor (tgf)-beta2 is a mediator of immunosuppression associated with malignant glioma and also influences pro-invasive functions. |
PubMedID- 23828734 | Currently, no strategies exist for the prevention or reversal of treatment-related immunosuppression in malignant glioma patients, although there are several promising theoretical approaches. |
Page: 1